Hemato-oncology
Neuropathic cancer pain: prevalence, pathophysiology, and management
So Young Yoon, Jeeyoung Oh
Korean J Intern Med. 2018;33(6):1058-1069. Published online June 25, 2018
Neuropathic cancer pain (NCP) is caused by nerve damage attributable to the cancer per se, and/or treatments including chemotherapy, radiotherapy, and surgery; the prevalence is reported to be as high as 40%. The etiologies of NCP include direct nerve invasion or nerve compression by the cancer, neu..
|